Abstract:OBJECTIVE:To investigate the specific anti-tumor immunity induced by gene immunization with ectopic hCG encoding gene.METHODS:BALB/c mice were immunized with plasmid TR421-hCGbeta coding for hCGbeta and mock DNA for 3 times at 3 weekly intervals. The level of specific anti-hCGbeta IgG antibody in the serum was determined by ELISA at the indicated time in the two groups. The growth inhibitory activity of the sera against tumor cells was examined in vitro by [(3)H]-Thymidine incorporation assay. Specific lympho-proliferation versus hCGbeta was detected by [(3)H]-Thymidine incorporation assay with hCGbeta protein or inactivated SP2/0-hCGbeta cells as specific stimulating antigen. Cytotoxic T lymphocyte (CTL) activity of the splenocytes derived from the immunized mice was measured by [(3)H]-Thymidine release assay. Protective assay was performed by subcutaneous inoculation of SP2/0-hCGbeta cells into the immunized mice. The weight and formation rate of the tumor were evaluated after challenge.RESULTS:All mice immunized with plasmid TR421-hCGbeta developed high level of anti-hCGbeta antibodies, which could inhibit the growth of Hela cells and SP2/0-hCGbeta cells compared with the serum from animals immunized with mock DNA (P < 0.05). The high-level specific lympho-proliferation against hCGbeta protein or/and inactivated SP2/0-hCGbeta cells were shown in TR421-hCGbeta immunized mice, whereas no significant proliferative activity was found in mock DNA immunized animals (P < 0.01). A strong cytotoxic activity against SP2/0-hCGbeta in TR421-hCGbeta immunized mice was found. Inoculation of SP2/0-hCGbeta cells into the mice immunized with mock DNA developed large tumors within 25 days. But a marked reduction of tumor weight and formation rate was found after the tumor cells challenge in the mice immunized with TR421-hCGbeta plasmid DNA (P < 0.01).CONCLUSION:The gene immunization of ectopic hCGbeta encoding gene, eliciting high-level of specific humoral and cellular immune responses, could inhibit the growth of tumor cells harboring ectopic hCGbeta in vitro and in vivo.

The Expression and Protective Efficacy of DNA Vaccine Encoding Antibodized Hgp100

Human gp100 induces specific anti- murine melanoma immune response, implicating a potential way to antitumor immunotherapy

Vaccination with A Dna Vaccine Based on Human Psca and Hsp70 Adjuvant Enhances the Antigen-Specific Cd8(+) T-Cell Response and Inhibits the Psca(+) Tumors Growth in Mice

HPV DNA vaccines expressing recombinant CRT/HPV6bE7 fusion protein inhibit tumor growth and angiogenic activity]

Anti-tumor Immunity with Dendritic Cells ( DC) Vaccine Modified by IL-18

Anti-Tumor Efficacy Induced by Antibodized PDTRP Gene Immunization

Effective oral delivery of gp100 plasmid vaccine against metastatic melanoma through multi-faceted blending-by-blending nanogels.

The humoral and cellular immune responses induced by HPV18L1-E6/E7 DNA vaccines in mice

Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.

Construction of a novel DNA vaccine against β-hCG and its anti-tumor effects combined with adjuvant GM-CSF

The Immunogenicity and Anti-tumor Efficacy of a Rationally Designed Neoantigen Vaccine for B16F10 Mouse Melanoma

[Specifics Anti-Tumor Immunity Induced by Gene Immunization with Ectopic Hcgbeta Encoding Gene].

Enhancing immunogenicity of HPV16 E7 DNA vaccine by conjugating codon-optimized GM-CSF to HPV16 E7 DNA

Potent Antitumor Effect Elicited by Gp96-Peptide Complexes Pulsed by Dendritic Cell on Mice of H22 Liver Cancer

Vaccination with a Potent DNA Vaccine Targeting B-cell Epitopes of Hgrp Induces Prophylactic and Therapeutic Antitumor Activity in Vivo.

The Specific Immune Response Elicited by Recombinant CRT120/HPV6bE7 DNA Vaccine in Mice

Peptide Vaccination – a Novel Therapeutically Option for Cancer Patients

Pcdnal1 Genetic Immunization Can Induce Specific Cell-Mediated Immune Responses in C57bl/6 Mice

[Antitumor Effect of Gene Gun-Mediated DNA Vaccine Pwrg-Neu Immunization in C57BL/6 Mice].

Th2-dominated Antitumor Immunity Induced by DNA Immunization with the Genes Coding for a Basal Core Peptide PDTRP and GM-CSF

[Immune Response to HIV-2 Gp105 DNA Vaccine in Mice].